Ms Tina Wallace, | |
4603 40th Ave, Kenosha, WI 53144-3543 | |
(262) 914-1981 | |
Not Available |
Full Name | Ms Tina Wallace |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 4603 40th Ave, Kenosha, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326484056 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 31662-31 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Tina Wallace, 4603 40th Ave, Kenosha, WI 53144-3543 Ph: (262) 914-1981 | Ms Tina Wallace, 4603 40th Ave, Kenosha, WI 53144-3543 Ph: (262) 914-1981 |
News Archive
A Toronto Star editorial reflects on the pledges of G8 countries to the Muskoka Initiative to improve maternal and child health care, noting, while Canada's $1.1 billion over five years "fell noticeably short of the $1.2 billion the G8 and G20 summits cost to stage, it will lend welcome impetus to a lifeline for Africa and help save lives." However, as the editorial notes, "the recession-battered G8 as a group responded feebly, mustering only $5 billion over five years.
A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.
Aspen was an early COVID-19 hot spot in Colorado, with a cluster of cases in March linked to tourists visiting for its world-famous skiing. Tests were in short supply, making it difficult to know how the virus was spreading.
The Centers for Disease Control and Prevention has awarded LSU Health New Orleans School of Public Health $15 million over five years for its cancer education, early detection, comprehensive control and registry programs.
Favorable results have led to crizotinib gaining approval for the treatment of advanced stage ALK-positive non-small cell lung cancer (NSCLC) in Japan, the United States, Canada, and several other countries in Europe and Asia.
› Verified 5 days ago
Mary Susan Bernardy, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 8207 22nd Ave, Kenosha, WI 53143 Phone: 224-610-8902 |